Register entry
Orient Pharma Co., Ltd. Yunlin Plant
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| TOFACITINIB | TOFACITINIB | tablet, film coated, extended release, oral | 76333-111ANDA |
Compare
Other companies listing tofacitinib
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Somerset Therapeutics Private Limited1 site · 187 NDC
- Novadoz Pharmaceuticals LLC0 sites · 249 NDC
- Exelan Pharmaceuticals, Inc.0 sites · 181 NDC
Enquiry
Common questions
- Is Orient Pharma Co., Ltd. Yunlin Plant FDA approved?
- Orient Pharma Co., Ltd. Yunlin Plant holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Orient Pharma Co., Ltd. Yunlin Plant make?
- 1 product is listed under Orient Pharma Co., Ltd. Yunlin Plant in the openFDA NDC Directory, most often as tablet, film coated, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.